PortfoliosLab logoPortfoliosLab logo
HIT vs. NBIS
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

HIT vs. NBIS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Health In Tech, Inc (HIT) and Nebius Group N.V. (NBIS). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

HIT vs. NBIS - Yearly Performance Comparison


2026 (YTD)20252024
HIT
Health In Tech, Inc
-8.81%-70.31%5.00%
NBIS
Nebius Group N.V.
23.96%202.18%-3.28%

Fundamentals

Market Cap

HIT:

$85.02M

NBIS:

$26.25B

EPS

HIT:

$0.02

NBIS:

$0.41

PE Ratio

HIT:

65.40

NBIS:

253.55

PEG Ratio

HIT:

0.07

NBIS:

87.12

PS Ratio

HIT:

2.51

NBIS:

48.22

PB Ratio

HIT:

4.97

NBIS:

5.69

Total Revenue (TTM)

HIT:

$33.33M

NBIS:

$534.20M

Gross Profit (TTM)

HIT:

$20.94M

NBIS:

$363.20M

EBITDA (TTM)

HIT:

$2.44M

NBIS:

-$276.75M

Returns By Period

In the year-to-date period, HIT achieves a -8.81% return, which is significantly lower than NBIS's 23.96% return.


HIT

1D
11.54%
1M
2.84%
YTD
-8.81%
6M
-54.83%
1Y
119.13%
3Y*
5Y*
10Y*

NBIS

1D
12.46%
1M
13.78%
YTD
23.96%
6M
-7.58%
1Y
391.52%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HIT vs. NBIS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HIT
HIT Risk / Return Rank: 7373
Overall Rank
HIT Sharpe Ratio Rank: 7474
Sharpe Ratio Rank
HIT Sortino Ratio Rank: 7979
Sortino Ratio Rank
HIT Omega Ratio Rank: 7474
Omega Ratio Rank
HIT Calmar Ratio Rank: 7171
Calmar Ratio Rank
HIT Martin Ratio Rank: 6565
Martin Ratio Rank

NBIS
NBIS Risk / Return Rank: 9696
Overall Rank
NBIS Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
NBIS Sortino Ratio Rank: 9797
Sortino Ratio Rank
NBIS Omega Ratio Rank: 9393
Omega Ratio Rank
NBIS Calmar Ratio Rank: 9898
Calmar Ratio Rank
NBIS Martin Ratio Rank: 9696
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HIT vs. NBIS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Health In Tech, Inc (HIT) and Nebius Group N.V. (NBIS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


HITNBISDifference

Sharpe ratio

Return per unit of total volatility

1.01

3.80

-2.80

Sortino ratio

Return per unit of downside risk

2.05

3.87

-1.83

Omega ratio

Gain probability vs. loss probability

1.25

1.44

-0.19

Calmar ratio

Return relative to maximum drawdown

1.54

8.03

-6.49

Martin ratio

Return relative to average drawdown

2.78

18.58

-15.80

HIT vs. NBIS - Sharpe Ratio Comparison

The current HIT Sharpe Ratio is 1.01, which is lower than the NBIS Sharpe Ratio of 3.80. The chart below compares the historical Sharpe Ratios of HIT and NBIS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


HITNBISDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.01

3.80

-2.80

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.46

2.04

-2.50

Correlation

The correlation between HIT and NBIS is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

HIT vs. NBIS - Dividend Comparison

Neither HIT nor NBIS has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

HIT vs. NBIS - Drawdown Comparison

The maximum HIT drawdown since its inception was -92.56%, which is greater than NBIS's maximum drawdown of -58.27%. Use the drawdown chart below to compare losses from any high point for HIT and NBIS.


Loading graphics...

Drawdown Indicators


HITNBISDifference

Max Drawdown

Largest peak-to-trough decline

-92.56%

-58.27%

-34.29%

Max Drawdown (1Y)

Largest decline over 1 year

-73.48%

-45.47%

-28.01%

Current Drawdown

Current decline from peak

-80.56%

-23.40%

-57.16%

Average Drawdown

Average peak-to-trough decline

-66.14%

-20.63%

-45.51%

Ulcer Index

Depth and duration of drawdowns from previous peaks

40.72%

19.65%

+21.07%

Volatility

HIT vs. NBIS - Volatility Comparison

Health In Tech, Inc (HIT) has a higher volatility of 36.86% compared to Nebius Group N.V. (NBIS) at 34.88%. This indicates that HIT's price experiences larger fluctuations and is considered to be riskier than NBIS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


HITNBISDifference

Volatility (1M)

Calculated over the trailing 1-month period

36.86%

34.88%

+1.98%

Volatility (6M)

Calculated over the trailing 6-month period

81.67%

68.31%

+13.36%

Volatility (1Y)

Calculated over the trailing 1-year period

119.13%

103.94%

+15.19%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

138.28%

111.65%

+26.63%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

138.28%

111.65%

+26.63%

Financials

HIT vs. NBIS - Financials Comparison

This section allows you to compare key financial metrics between Health In Tech, Inc and Nebius Group N.V.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B2.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
7.51M
227.70M
(HIT) Total Revenue
(NBIS) Total Revenue
Values in USD except per share items